Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | AMGN | GILD | VRTX | BIIB |
| Company | Adaptimmune Ther ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.0500 | 336.80 | 84.20 | 483.78 | 199.79 |
| High | 1.0500 | 336.80 | 84.20 | 483.78 | 199.79 |
| Low | 1.0500 | 336.80 | 84.20 | 473.75 | 199.79 |
| Last | 1.0500 | 336.80 | 84.20 | 474.16 | 199.79 |
| Change | +0.0100 | +3.88 | +0.31 | -7.10 | +2.20 |
| % Change | +0.96% | +1.17% | +0.37% | -1.48% | +1.11% |
| Volume | 1,009 | 4,015 | 64,431 | 868,200 | 990 |
| 20-Day Average Volume | 1,016,045 | 1,679,576 | 6,258,242 | 980,545 | 772,365 |
| Previous Close | 1.0400 | 332.92 | 83.89 | 481.26 | 197.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1475 | 329.63 | 80.09 | 480.27 | 201.52 |
| 20-Day Raw Stochastic | 9.68% | 89.00% | 92.77% | 34.05% | 51.96% |
| 20-Day Relative Strength | 44.62% | 58.29% | 72.45% | 47.32% | 42.92% |
| Weighted Alpha | -20.06 | +27.54 | +18.82 | +32.08 | -22.50 |
| Today's Opinion | 24% Sell | 96% Buy | 88% Buy | 40% Buy | 100% Sell |
| Previous Opinion | 24% Sell | 88% Buy | 88% Buy | 56% Buy | 100% Sell |
| Last Month's Opinion | 8% Sell | 88% Buy | 56% Buy | 88% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.55% since 09/12/24 | +2.04% since 09/12/24 | +1.25% since 09/12/24 | -0.12% since 09/11/24 | +0.96% since 09/12/24 |
| Low | 1.0200 on 09/18/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 468.46 on 09/12/24 | 192.25 on 09/13/24 |
| High | 1.1650 on 09/13/24 | 339.00 on 09/18/24 | 84.52 on 09/18/24 | 490.15 on 09/16/24 | 202.79 on 09/17/24 |
| 1-Month | |||||
| %Chg | -6.25% since 08/19/24 | +2.69% since 08/19/24 | +13.10% since 08/19/24 | -0.67% since 08/16/24 | -3.04% since 08/19/24 |
| Low | 1.0200 on 09/18/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 460.69 on 09/11/24 | 192.25 on 09/13/24 |
| High | 1.3300 on 08/26/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | +19.32% since 06/18/24 | +10.07% since 06/18/24 | +33.33% since 06/18/24 | +1.47% since 06/18/24 | -10.67% since 06/18/24 |
| Low | 0.8250 on 06/26/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 | 192.25 on 09/13/24 |
| High | 1.4800 on 07/30/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | -25.53% since 03/19/24 | +23.95% since 03/19/24 | +14.70% since 03/19/24 | +15.26% since 03/18/24 | -8.62% since 03/19/24 |
| Low | 0.8250 on 06/26/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 1.6500 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 256,698 | 178,589,936 | 104,514,608 | 122,358,416 | 28,768,510 |
| Shares Outstanding, K | 246,825 | 536,435 | 1,245,853 | 258,053 | 145,597 |
| Annual Sales | 60,280,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -113,870,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 128,230,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 2,464,900,000 |
| Last Quarter Net Income | 69,520,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 583,600,000 |
| 60-Month Beta | 2.21 | 0.61 | 0.18 | 0.40 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.27 on 08/12/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 5.28 on 08/01/24 |
| Latest Earnings Date | 08/12/24 | 10/29/24 | 11/05/24 | 11/04/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.89 | 17.67 | 0.00 | 12.19 |